EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study

Bente Mertz Nørgård iD, Caroline Theilgaard Thorarinsson iD, Jan Nielsen iD, Mette Louise Andersen iD, Jens Kjeldsen iD, Torben Knudsen iD, Rahul S Dalal iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70316 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Bente Mertz Nørgård und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Analgesics, Opioid, Colitis, Ulcerative, Opioid-Related Disorders, Crohn Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Aage og Johanne Louis-Hansens Fond, Denmark, Østifterne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pain is common in patients with Crohn's disease (CD) and ulcerative colitis (UC), and a substantial proportion develop chronic opioid use (COU). We examined the persistence of COU over time and identified factors predicting persistent use.

Methods

This nationwide Danish cohort study included patients with an initial period of COU (definition: ≥3 opioid prescriptions within 12 months with at least 30 days between prescriptions). We examined persistent COU for 2 years thereafter. Predictors for persistent COU were examined in multivariable logistic regression analyses.

Results

Among 6208 patients with COU, 49.6% had persistent COU in the first follow‐up year: 30.4% with only weak opioids, 11.7% with weak/strong opioids and 7.5% with only strong opioids. In the second follow‐up year, two‐thirds of those with persistent COU remained chronic users. Among 2553 patients with CD, key predictors of persistent COU in the first year of follow‐up were age ≥70 years at disease onset (adjusted odds ratio [aOR] = 1.73, 95% CI: 1.22–2.45) and antidepressant use (aOR = 1.44, 95% CI: 1.18–1.75). Among the 3655 patients with UC, predictors included high comorbidity (aOR = 1.45, 95% CI: 1.05–2.00), age ≥70 years (aOR = 1.41, 95% CI: 1.09–1.82) and anxiolytic use (aOR = 1.38, 95% CI: 1.12–1.71).

Conclusions

After an initial period of COU, half of all patients had persistent COU after 1 year, and among these two‐thirds still had COU after an additional year. The main predictors of persistent COU were factors related to vulnerability (advanced age and mental health conditions).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidColitis, UlcerativeOpioid-Related DisordersCrohn DiseaseChronic PainHumansFemaleMaleMiddle AgedDenmarkAdultAgedCohort StudiesFollow-Up StudiesAge FactorsAntidepressive AgentsYoung AdultRisk Factors

Stichwörter der Autor:innen

chronic paininflammatory bowel diseaseopioid

Substanzen

Analgesics, OpioidAntidepressive Agents

Autor:innen und Institutionen

  • Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
  • Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.
  • Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Medical Gastroenterology, Hospital of Southwest Jutland, Esbjerg, Denmark.
  • Department of Regional Health Science, University of Southern Denmark, Esbjerg, Denmark.

ORCID-Profile: Bente Mertz Nørgård, Caroline Theilgaard Thorarinsson, Jan Nielsen, Mette Louise Andersen, Jens Kjeldsen, Torben Knudsen, Rahul S Dalal

Förderung

  • Aage og Johanne Louis-Hansens Fond, Denmark
  • Østifterne

Zitieren

APA

Nørgård, B. M., Thorarinsson, C. T., Nielsen, J., Andersen, M. L., Kjeldsen, J., Knudsen, T., & Dalal, R. S. (2026). The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70316

Vancouver

Nørgård BM, Thorarinsson CT, Nielsen J, Andersen ML, Kjeldsen J, Knudsen T, et al. The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70316

BibTeX
@article{Nrgrd2026,
  author = {Nørgård, Bente Mertz and Thorarinsson, Caroline Theilgaard and Nielsen, Jan and Andersen, Mette Louise and Kjeldsen, Jens and Knudsen, Torben and Dalal, Rahul S},
  title = {The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70316}
}
Kostenlos starten →